Cancer

October 2, 2025

Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma

Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A combination of the immune checkpoint blocker,...

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Radiotherapy to the prostate improves overall survival...

Olaparib maintenance extends PFS by estimated 3 years in advanced ovarian cancer

Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP...

HIV-infected Hispanic adults face higher risks of HPV-related cancers

A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers...

New treatment approach for advanced anal cancer

ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP)...

Future fertility: Giving hope to men who received childhood cancer treatment

Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined...

Oncologists demand more education on the use of biosimilars: ESMO takes action

Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines...

Multi-strain probiotic reduces chemotherapy-induced diarrhoea [ESMO 2018 Press Release]

Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps...

Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer

Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the...

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors...

Targeting specific genomic mutation in breast cancer improves outcomes, first study shows

(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced...

Bright lights, big CITI

Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a...

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Immunotherapy with nivolumab and low-dose ipilimumab could...

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Pre-operative treatment with a combination of the...

Abramson Cancer Center receives $10.7 million to study CAR T cells in solid tumors

PHILADELPHIA - A new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center...

Father’s nicotine exposure may cause problems in future generations of his children

Credit: FSU College of Medicine TALLAHASSEE, Fla. -- While women have long been warned about the dangers of smoking during...

Adding refined fiber to processed food could have negative health effects, study finds

Credit: Georgia State University ATLANTA--Adding highly refined fiber to processed foods could have negative effects on human health, such as...

UTA, Texas A&M create Texas Genomics Core Alliance

Texas A&M University and The University of Texas at Arlington have established The Texas Genomics Core Alliance to increase access...

Huge variations between countries in time for reimbursement decisions on new cancer drugs

Munich, Germany, 19 October 2018 - Some European countries take more than twice as long as others to reach health...

Women may experience more side effects than men during gastric cancer chemotherapy